IT1258315B - Derivati del flavone - Google Patents

Derivati del flavone

Info

Publication number
IT1258315B
IT1258315B ITMI920884A ITMI920884A IT1258315B IT 1258315 B IT1258315 B IT 1258315B IT MI920884 A ITMI920884 A IT MI920884A IT MI920884 A ITMI920884 A IT MI920884A IT 1258315 B IT1258315 B IT 1258315B
Authority
IT
Italy
Prior art keywords
flavone derivatives
flavone
therapies
powerful
acting
Prior art date
Application number
ITMI920884A
Other languages
English (en)
Inventor
Amedeo Leonardi
Gianni Motta
Carlo Riva
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of ITMI920884A0 publication Critical patent/ITMI920884A0/it
Priority to ITMI920884A priority Critical patent/IT1258315B/it
Priority to DK93302598.3T priority patent/DK0566288T3/da
Priority to DE69300318T priority patent/DE69300318T2/de
Priority to AT93302598T priority patent/ATE125807T1/de
Priority to EP93302598A priority patent/EP0566288B1/en
Priority to ES93302598T priority patent/ES2078101T3/es
Priority to US08/045,420 priority patent/US5453518A/en
Priority to JP5083383A priority patent/JPH0625213A/ja
Publication of ITMI920884A1 publication Critical patent/ITMI920884A1/it
Priority to GR950402904T priority patent/GR3017801T3/el
Application granted granted Critical
Publication of IT1258315B publication Critical patent/IT1258315B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Vengono descritti nuovi derivati amminici del flavone dotati di potente attività spasmolitica ed utili come agenti terapeutici antispasmodici a lungo effetto da utilizzarsi particolarmente nelle terapie dei disturbi del basso tratto urinario. Vengono anche descritti i procedimento per ottenere detti composti.
ITMI920884A 1992-04-10 1992-04-10 Derivati del flavone IT1258315B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ITMI920884A IT1258315B (it) 1992-04-10 1992-04-10 Derivati del flavone
EP93302598A EP0566288B1 (en) 1992-04-10 1993-04-01 Flavone derivatives
DE69300318T DE69300318T2 (de) 1992-04-10 1993-04-01 Flavonderivate.
AT93302598T ATE125807T1 (de) 1992-04-10 1993-04-01 Flavonderivate.
DK93302598.3T DK0566288T3 (da) 1992-04-10 1993-04-01 Flavon-derivater
ES93302598T ES2078101T3 (es) 1992-04-10 1993-04-01 Derivados de flavona.
US08/045,420 US5453518A (en) 1992-04-10 1993-04-09 Flavone derivatives
JP5083383A JPH0625213A (ja) 1992-04-10 1993-04-09 フラボン誘導体
GR950402904T GR3017801T3 (en) 1992-04-10 1995-10-18 Flavone derivatives.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI920884A IT1258315B (it) 1992-04-10 1992-04-10 Derivati del flavone

Publications (3)

Publication Number Publication Date
ITMI920884A0 ITMI920884A0 (it) 1992-04-10
ITMI920884A1 ITMI920884A1 (it) 1993-10-10
IT1258315B true IT1258315B (it) 1996-02-22

Family

ID=11362893

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI920884A IT1258315B (it) 1992-04-10 1992-04-10 Derivati del flavone

Country Status (9)

Country Link
US (1) US5453518A (it)
EP (1) EP0566288B1 (it)
JP (1) JPH0625213A (it)
AT (1) ATE125807T1 (it)
DE (1) DE69300318T2 (it)
DK (1) DK0566288T3 (it)
ES (1) ES2078101T3 (it)
GR (1) GR3017801T3 (it)
IT (1) IT1258315B (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
CA2204082A1 (en) * 1996-05-03 1997-11-03 Michael William John Urquhart Pharmaceutical compounds
US6146387A (en) * 1998-08-26 2000-11-14 Linvatec Corporation Cannulated tissue anchor system
US20070078120A1 (en) * 2003-10-21 2007-04-05 Hitoshi Ban Novel piperidine derivative
US7783260B2 (en) * 2006-04-27 2010-08-24 Crestcom, Inc. Method and apparatus for adaptively controlling signals

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE401653C (de) * 1924-09-08 Hugo Lentz Fluessigkeitsgetriebe
FR435749A (fr) * 1911-10-27 1912-03-08 Arthur Henry Johnson Perfectionnements aux tringles d'écartement pour aiguilles de chemins de fer
US2921070A (en) * 1957-11-05 1960-01-12 Recordati Lab Farmacologico S Basic esters of 3-methylflavone-8-carboxylic acid
US3350411A (en) * 1963-10-10 1967-10-31 Pharma Seceph S A Soc D Expl C Process for preparing 3-methylflavone-8-carboxylic acid
US3277094A (en) * 1965-05-10 1966-10-04 Ciba Geigy Corp Piperazine derivatives
DE1670200A1 (de) * 1967-03-22 1972-03-02 Byk Gulden Lomberg Chem Fab Neue arylsubstituierte Piperazinylcarbonsaeureanilide und Verfahren zu deren Herstellung
DE2123923A1 (de) * 1971-05-14 1972-11-23 Boehringer Mannheim Gmbh, 6800 Mannheim 4-eckige Klammer auf omega- (Flavon-7yl-oxy) -alkyl eckige Klammer zu -pigerazin-Derivate und Verfahren zu ihrer Herstellung
BE790074A (fr) * 1971-10-21 1973-02-01 Blaise Rolland Nouveaux composes derives de la tetrahydroisoquinoleine et la gamma-benzopyrone et leurs procedes de preparation
US4089969A (en) * 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4684651A (en) * 1981-03-17 1987-08-04 Mitsubishi Chemical Industries Limited Alkylenedioxybenzene and acid addition salts thereof useful as hypotensives
US4668804A (en) * 1981-05-01 1987-05-26 Pennwalt Corporation Chromones
CA1188311A (en) * 1981-05-01 1985-06-04 Edwin S. Wu Antihypertensive agents
US4668805A (en) * 1981-05-01 1987-05-26 Pennwalt Corporation Chromones
US4495198A (en) * 1981-05-01 1985-01-22 Pennwalt Corporation Antihypertensive chromonoxypropanolamines
NZ200981A (en) * 1981-07-17 1984-10-19 Recordati Chem Pharm 3-methylflavone-8-carboxylic acid derivatives and pharmaceutical compositions
AU8045382A (en) * 1981-12-14 1983-06-23 Pennwalt Corp. Chromones
JPS58225083A (ja) * 1982-06-23 1983-12-27 Nippon Shinyaku Co Ltd メチルフラボン誘導体
JPS5955878A (ja) * 1982-09-24 1984-03-31 Chugai Pharmaceut Co Ltd 新規なフエニルピペラジン誘導体
JPS5967281A (ja) * 1982-09-30 1984-04-16 Yamamoto Kagaku Kogyo Kk ３−メチルフラボン−８−カルボン酸誘導体及びその製造法
US4525356A (en) * 1982-11-02 1985-06-25 Hokuriku Pharmaceutical Co., Ltd. N-substituted flavone-8-carboxamides
GB8303946D0 (en) * 1983-02-12 1983-03-16 Recordati Chem Pharm Antihypertensive n-piperazinylalkanoylanilides
US4539318A (en) * 1984-06-04 1985-09-03 Merck & Co., Inc. Tertiary aminohydroxypropoxy substituted thiadiazoles, pharmaceutical compositions and use
US4585773A (en) * 1984-07-11 1986-04-29 Bristol-Myers Company Isoindolinyl-alkyl-piperazines
US4678787A (en) * 1985-01-30 1987-07-07 Warner-Lambert Company 4H-1-benzopyran-4-ones and their sulfur containing analogs
NZ212525A (en) * 1985-06-24 1989-02-24 Dfc New Zealand Ltd Formerly D Nitrogen-containing heterocyclic compounds, and pharmaceutical compositions containing such
US4797498A (en) * 1986-07-18 1989-01-10 Pennwalt Corporation Flavonoxypropanolamines and esters of flavonoxypropanolamines as antiarrhythmic agents
HU202108B (en) * 1986-07-30 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol
JPS63139180A (ja) * 1986-12-02 1988-06-10 Tanabe Seiyaku Co Ltd カルボン酸誘導体
US4889941A (en) * 1987-04-23 1989-12-26 Fisons Corporation Synthetic flavonoids as inhibitors of leukotrienes and 5-lipoxygenase
IT1219876B (it) * 1988-03-18 1990-05-24 Malesci Sas 1-(2-etossi-2-(3'piridil)etil)-4-(2-metossi-fenil)piperazina per il trattamento delle disfunzioni del tratto urinario inferiore e della ipertrofia prostatica bengina
CA1340113C (en) * 1988-05-24 1998-11-03 Magid A. Abou-Gharbia Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity
JPH01299284A (ja) * 1988-05-26 1989-12-04 Kyoto Yakuhin Kogyo Kk フラボン誘導体
FR2637596B1 (fr) * 1988-10-11 1992-09-04 Irceba Methyl-4 ((aryl-4 piperazinyl-1)-2 ethyl)-5 thiazole et ses derives, leur procede de preparation et les medicaments en contenant
IE62890B1 (en) * 1988-12-06 1995-03-08 Hafslund Nycomed Pharma New piperazinylalkyl-3(2h)-pyridazinones process for the preparation thereof and the use thereof as agents lowering blood pressure
JPH03173885A (ja) * 1989-12-01 1991-07-29 Mitsui Toatsu Chem Inc ピリミジンジオン誘導体化合物、該化合物の製造法および該化合物を含む抗不整脈剤
US5278174A (en) * 1990-06-04 1994-01-11 Scios Nova, Inc. Sigma binding site agents
US5091182A (en) * 1990-07-23 1992-02-25 Syntex (U.S.A.) Inc. Dispensing units for ketorolac topical gel formlations
ATE161837T1 (de) * 1990-07-25 1998-01-15 Teijin Ltd Benzopyran derivat, seine darstellung und pharmazeutische zusammensetzung, welche dieses enthält
FR2691149B1 (fr) * 1992-05-18 1994-07-08 Adir Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
ES2078101T3 (es) 1995-12-01
JPH0625213A (ja) 1994-02-01
EP0566288A1 (en) 1993-10-20
DE69300318T2 (de) 1996-01-25
DE69300318D1 (de) 1995-09-07
ATE125807T1 (de) 1995-08-15
ITMI920884A0 (it) 1992-04-10
US5453518A (en) 1995-09-26
ITMI920884A1 (it) 1993-10-10
GR3017801T3 (en) 1996-01-31
EP0566288B1 (en) 1995-08-02
DK0566288T3 (da) 1995-10-02

Similar Documents

Publication Publication Date Title
LV12794B (en) Pharmaceutically active bicyclic-heterocyclic amines
HK1005985A1 (en) Combined use of hyaluronic acid and therapeutic agents to improve the therapeutic effect
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
ATE194767T1 (de) In liposomen verkapseltes taxol und verwendungsverfahren
DE69518729D1 (de) Stickstoffoxyd abgebendes präparat zur behandlung von analen erkrankungen
HUT62802A (en) Process for producing locally applicable pharmaceutical compositions comprising collagenase in large dose
MX9803753A (es) Acidos alfa-iminohidroxamicos y -carboxilicos n-sustituidos ciclicos y heterociclicos.
EP0378086A3 (de) Verwendung des Wirkstoffs Azelastin zur Bekämpfung von Psoriasis-Erkrankungen
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
DE68912195T2 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
IT1208452B (it) Preparati farmaceutici con efficacia analgesica, nonche' loro produzione ed impiego
WO1987000432A3 (en) Use of melatonin or related compounds for the treatment of psoriasis
IT1258315B (it) Derivati del flavone
ES2058293T3 (es) 2,3-dihidroergolinas para mejorar la funcion serotonergica.
ATE136465T1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
FI98456B (fi) Menetelmä terapeuttisesti aktiivisten 1-piperidinyylialkanoyyliaryylisulfonamidijohdannaisten valmistamiseksi
MX9304878A (es) Uso de un azaspirano substituido en la fabricacion de un medicamento para utilizarse en el tratamiento de psoriasis.
LV10952A (lv) Terapeitiski aktivi fluoraizvietoti benzimidazoli to iegusanas panemieni mineto terapeitiski aktivo fluoraizvietoto benzimidazolu pielietojums
DE3777411D1 (de) Mittel zur verbesserung der perkutanen verabreichung von arzneimitteln.
AU2790189A (en) Use of compounds of the retuline series as compounds with pharmaceutical activity, in particular analgesic, antispasmodic and antiinflammatory medicaments
RU92001939A (ru) Способ лечения псориаза
IT1232963B (it) Composizioni farmaceutiche topiche contenenti antiistaminici h2
DE58905981D1 (de) Verwendung von hexatrienderivaten zur herstellung von mitteln gegen akne, psoriasis und lichtschäden der haut.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950404